Press Releases

NetNoggin® releases results from "Levels of Caregiving for Patients with Alzheimer's Disease"

image4

 FREDERICK, Md., July 17, 2019 /PRNewswire/ -- NetNoggin® released detailed results from a netnographic-qualitative research study, which investigated levels of caregiving for patients with Alzheimer's disease and was presented at the Alzheimer's Association International Conference® (AAIC) 2019, held in Los Angeles, California, July 14 – 18.  

Read Article

NetNoggin® releases results from "Utilization of Technology in Alzheimer's Disease"

image5

 FREDERICK, Md., July 16, 2019 /PRNewswire/ -- NetNoggin® released detailed results from a netnographic-qualitative research study, which investigated the utilization of technology in Alzheimer's disease (including mild cognitive impairment [MCI]), presented at the Alzheimer's Association International Conference® (AAIC) 2019 held in Los Angeles, California, July 14 - 18. 

Read Article

NetNoggin® announces the release of NetNog: #genesis® NASH (including NAFL)

image6

 

FREDERICK, Md., May 21, 2019 /PRNewswire/ -- NetNoggin®, a premier market research agency that specializes in pharmaceutical marketing, has announced the release of its newest research, NetNog: #genesis® Nonalcoholic Steatohepatitis (NASH) (including Nonalcoholic Fatty Liver [NAFL]). 

Read Article

NetNoggin® research to be presented at the 2019 Alzheimer's Association International Conference

image7

 FREDERICK, Md., April 4, 2019 /PRNewswire/ -- NetNoggin® announced they will present additional findings from their Alzheimer's disease research report at the upcoming Alzheimer's Association International Conference (AAIC®). 

Read Article

NetNoggin® announces the release of NetNog: #genesis® Cystic Fibrosis Patient and Caregiver Journeys

image8

 FREDERICK, Md., Feb. 26, 2019 /PRNewswire/ -- In honor of Rare Disease Day on Thursday, NetNoggin®, a premier market research agency that specializes in pharmaceutical marketing, has announced the release of its newest offering, NetNog: #genesis® Cystic Fibrosis Patient and Caregiver Journeys. 

Read Article

NetNoggin® announces the release of NetNog: #genesis® Alzheimer's Disease (incl. MCI)

image9

 FREDERICK, Md., Nov. 8, 2018 /PRNewswire/ -- NetNoggin®, a premier market research agency that specializes in pharmaceutical marketing, has announced the release of its newest research, NetNog: #genesis® Alzheimer's Disease (including Mild Cognitive Impairment [MCI]) 

Read Article

NetNoggin® announces the release of NetNog: #genesis® Cystic Fibrosis research

image10

 FREDERICK, Md., Oct. 19, 2018 /PRNewswire/ -- NetNoggin®, a premier market research agency that specializes in pharmaceutical marketing, has announced the release of its newest research, NetNog: #genesis® Cystic Fibrosis. 

Read Article

NetNoggin® announces the release of NetNog: #genesis®

image11

 FREDERICK, Md., Oct. 17, 2018 /PRNewswire/ -- NetNoggin® has released its newest product, NetNog: #genesis®, offering pharmaceutical companies unmatched insights into their patients' and caregivers' real world lexicon, unmet needs, treatment flow process, and journey. 

Read article